67 filings
Page 2 of 4
FWP
9tffcpsk
10 Jul 17
Free writing prospectus
12:00am
8-K
wff0g0
26 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
s1g fzkfh
12 May 17
PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am
DEF 14A
p44iqjt 9mf7czycwv
13 Apr 17
Definitive proxy
12:00am
10-K
23klrxfu ba7voh
27 Mar 17
Annual report
12:00am
S-8
r70vcmzb 77mdn3
27 Mar 17
Registration of securities for employees
12:00am
8-K
hshprad65txmjc
27 Mar 17
PhaseRx Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
12:00am
8-K
3rbm5q1
8 Mar 17
Regulation FD Disclosure
12:00am
8-K
u7mpg794
6 Mar 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
s8y8zape3soy
28 Nov 16
PhaseRx Receives Orphan Drug Designation from FDA for PRX-OTC for the Treatment of Ornithine Transcarbamylase Deficiency
12:00am
8-K
dhh hfy88vsefqc1
8 Nov 16
Regulation FD Disclosure
12:00am
8-K
kmbtbyi dv
7 Nov 16
PhaseRx Reports Third Quarter 2016 Financial Results and Provides Corporate Update
12:00am
8-K
zuwb5kt ht
24 Aug 16
Departure of Directors or Certain Officers
12:00am
S-8
0ng1vcmseyel
12 Aug 16
Registration of securities for employees
12:00am
8-K
66qant9
2 Aug 16
PhaseRx Reports Second Quarter 2016 Financial Results and Provides Corporate Update
12:00am